October 9, 2020
News! Our proposed work on the impact of COVID-19 on opioid treatment organizational was included in the Financial Times.
Check out a quick video with 15-second contributions from members of the academy of management on the impact of COVID-19 on business and organizations.
Continue Reading here.
July 16, 2020
Thank you to all those who have joined us in previous webinars in our ongoing series “FORE’s COVID-19 National Emergency Response: Maintaining Access to MOUD.”
The COVID-19 pandemic and recent events have magnified the existing racial and ethnic disparities in our healthcare systems, including in opioid use disorder (OUD) treatment. While our understanding of and ability to treat OUD has progressed over the past decade, the benefits of this shift have not been made equally available to all who need it. Black Americans are much less likely than their white counterparts to receive treatment for their opioid use disorder, even though both groups are affected at similar rates, and in 2016, fatal opioid overdoses among Black Americans were nearly double that of the general population. The COVID-19 pandemic is likely to further exacerbate these disparities.
Please join us on Thursday, July 16th at 3pm EST as we welcome…
… as they lead a discussion on racial and ethnic disparities in accessing evidence-based OUD treatment, the impact of the pandemic, and potential solutions towards a more equitable system of care. An open Q&A session will follow the presentation.
Original post published at the FORE Website.
Access programs from our partner institutions. Coming Soon.